Effects of a 3-day low-fat diet on metabolic control, insulin sensitivity, lipids and adipocyte hormones in Norwegian subjects with hypertriacylglycerolaemia and type 2 diabetes

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 64, Issue 6, 2004, Pages 565-574

  Mostad, I L ^a,b   Qvigstad, E ^a   Bjerve, K S ^a   Grill, V E ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Adiponectin; Leptin; Low fat diet; Type 2 diabetes

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; INSULIN; LEPTIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TRIACYLGLYCEROL;

ADIPOCYTE; ADULT; AGED; ARTICLE; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY FIBER; DIETARY INTAKE; FEMALE; FOOD COMPOSITION; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID METABOLISM; LOW FAT DIET; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; PRIORITY JOURNAL; SEX DIFFERENCE; SHORT COURSE THERAPY; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET, FAT-RESTRICTED; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; LIPIDS; MALE; MIDDLE AGED; NORWAY;

EID: 4844231185     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510410007053     Document Type: Article

References (41)

1. Riccardi G, Parillo M. Comparison of the metabolic effects of fat-modified vs low fat diets. Ann NY Acad Sci 1993; 683: 192-8.
2. Storlien LH, Borkman M, Jenkins AB, Campbell LV. Diet and in vivo insulin action: of rats and man. Diabetes Nutr Metab 1991; 4: 227-40.
3. Berry EM. Dietary fatty acids in the management of diabetes mellitus. Am J Clin Nutr 1997; 66: 991S-7S.
4. Kraegen EW, James DE, Storlien LH, Burleigh KM, Chisholm DJ. In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration. Diabetologia 1986; 29: 192-8.
5. Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol 1986; 251: E576-83.
6. Swinburn BA. Effect of dietary lipid on insulin action. Clinical studies. Ann NY Acad Sci 1993; 683: 102-9.
7. Markovic TP, Jenkins AB, Campbell LV, Furler SM, Kraegen EW, Chisholm DJ. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM. Diabetes Care 1998; 21: 687-94.
8. de Man FH, van der LA, Hopman EG, Gevers Leuven JA, Onkenhout W, Dallinga-Thie GM, Smelt AH. Dietary counselling effectively improves lipid levels in patients with endogenous hypertriglyceridemia: emphasis on weight reduction and alcohol limitation. Eur J Clin Nutr 1999; 53: 413-8.
9. Kolterman OG, Greenfield M, Reaven GM, Saekow M, Olefsky JM. Effect of a high carbohydrate diet on insulin binding to adipocytes and on insulin action in vivo in man. Diabetes 1979; 28: 731-6.
10. Chen M, Bergman RN, Porte D, Jr. Insulin resistance and beta-cell dysfunction in aging: the importance of dietary carbohydrate. J Clin Endocrinol Metab 1988; 67: 951-7.
11. The Norwegian recommendations of food and nutrient intake SEF Norske næringsstoffanbefalinger 1997. In Norwegian.
12. Nes M, Frost AL, Solvoll K, Sandstad B, Hustvedt BE, Lovo A, Drevon CA. Accuracy of a quantitative food frequency questionnaire applied in elderly Norwegian women. Eur J Clin Nutr 1992; 46: 809-21.
13. Qvigstad E, Mostad IL, Bjerve KS, Grill VE. Acute lowering of circulating fatty acids improves insulin secretion in a subset of type 2 diabetes subjects. Am J Physiol Endocrinol Metab 2003; 284: E129-37.
14. Rimestad AH, Blaker B, Flåten A-M, Nordbotten A. Den store matvaretabellen (The Norwegian Food Table). Oslo: Universitetsforlaget; 1995. In Norwegian.
15. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83: 2694-8.
16. Albareda M, Rodriguez-Espinosa J, Murugo M, de Leiva A, Corcoy R. Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 2000; 43: 1507-11.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
18. NCEP. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486-97.
19. Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G. UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab 1997; 82: 654-7.
20. Bjerve KS, Brubakk AM, Fougner KJ, Johnsen H, Midthjell K, Vik T. Omega-3 fatty acids: essential fatty acids with important biological effects, and serum phospholipid fatty acids as markers of dietary omega 3-fatty acid intake. Am J Clin Nutr 1993; 57: 801S-5S.
21. Andersen LF, Solvoll K, Drevon CA. Very-long-chain n-3 fatty acids as biomarkers for intake of fish and n-3 fatty acid concentrates. Am J Clin Nutr 1996; 64: 305-11.
22. Ma J, Folsom AR, Shahar E, Eckfeldt JH. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) study investigators. Am J Clin Nutr 1995; 62: 564-71.
23. Bachmann OP, Dahl DB, Brechtel K, Machann J, Haap M, Maier T, Loviscach M, Stumvoll M, Claussen CD, Schick F, Håring HU, Jacob S. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 2001; 50: 2579-84.
24. Heilbronn LK, Noakes M, Clifton PM. Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes. Diabetes Care 1999; 22: 889-95.
25. Grill V, Qvigstad E. Fatty acids and insulin secretion Br J Nutr 2000; 83: Suppl. 1: S79-84.
26. Kieffer TJ, Habener JF. The adipoinsular axis: effects of leptin on pancreatic beta-cells. Am J Physiol Endocrinol Metab 2001; 278: E1-14.
27. Ceddia RB, Koistinen HA, Zierath JR, Sweeney G. Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J 2002; 16: 1163-76.
28. Surwit RS, Petro AE, Parekh P, Collins S. Low plasma leptin in response to dietary fat in diabetes- and obesity-prone mice. Diabetes 1997; 46: 1516-20.
29. Jenkins AB, Markovic TP, Fleury A, Campbell LV. Carbohydrate intake and short-term regulation of leptin in humans. Diabetologia 1997; 40: 348-51.
30. Coleman RA, Herrmann TS. Nutritional regulation of leptin in humans. Diabetologia 1999; 42: 639-46.
31. Reseland JE, Haugen F, Hollung K, Solvoll K, Halvorsen B, Brude IR, Nenseter MS, Christiansen EN, Drevon CA. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 2001; 42: 743-50.
32. Dubuc GR, Phinney SD, Stern JS, Havel PJ. Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism 1998; 47: 429-34.
33. Díez JJ, Iglesias P. The role of novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003; 148: 293-300.
34. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-5.
35. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxial decrease of an adipocyte-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
36. Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S, Kris-Etherton PM. Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 1999; 69: 632-46.
37. Grundy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res 1990; 31: 1149-72.
38. Clarke R, Frost C, Collins R, Appleby P, Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. Br Med J 1997; 314: 112-27.
39. Garg A, Grundy SM, Unger RH. Comparison of effects of high and low carbohydrate diets on plasma lipoproteins and insulin sensitivity in patients with mild NIDDM. Diabetes 1992; 41: 1278-85.
40. Hooper L, Summerbell CD, Higgins JP, Thompson RL, Capps NE, Smith GD, Riemersma RA, Ebrahim S. Dietary fat intake and prevention of cardiovascular disease: systematic review. Br Med J 2001; 322: 757-63.
41. Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 2001; 20: 5-19.